Justin Yap

Justin is a Non-Executive Director of Hexima Limited, a biotechnology company using plant derived peptides to address unmet medical needs in anti-infective therapeutic settings. He is a Non-Executive Director of CathRx Limited, an Australian medical device company commercialising cardiac electrophysiology catheters for the treatment of heart rhythm disorders. Prior to this, he began his career in investment banking for Mosaic Risk Management Pty Ltd, a wholly owned subsidiary of Wilson HTM Limited specialising in derivatives risk management.